Corpus Intelligence IC Memo — HCA FLORIDA JFK HOSPITAL 2026-04-26 03:58 UTC
IC Memo — HCA FLORIDA JFK HOSPITAL
Investment Committee Memorandum | FL | 582 beds | Grade C | EBITDA uplift $50.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA JFK HOSPITAL

CCN 100080 | PALM BEACH, FL | 582 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA JFK HOSPITAL is a 582-bed suburban community hospital in PALM BEACH, FL with $688.3M in net patient revenue and a 13.3% operating margin. The hospital serves a payer mix of 21.5% Medicare, 5.0% Medicaid, and 73.5% commercial.

Thesis: Platform Growth. Our ML models identify $50.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.3% to 20.7% (+736bps).

Net Revenue HCRIS$688.3M
Current EBITDA COMPUTED$91.5M
Operating Margin COMPUTED13.3%
Occupancy HCRIS67.1%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS9.3%
Distress Probability ML43.5%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
56
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 13.3% places it above the state median. Among 56 size-comparable peers (291-1164 beds), the median margin is 5.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (291-1164), prioritizing same-state peers. 56 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA JFK HOSPITAL (Target)FL582$688.3M13.3%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
UF HEALTH SHANDSFL994$2.24B10.4%
BAPTIST MEDICAL CENTERFL980$1.78B0.9%
TAMPA GENERAL HOSPITALFL898$1.73B-9.3%
BAPTIST HOSPITALFL948$1.71B10.8%
MEMORIAL REGIONAL HOSPITALFL838$1.45B-20.7%
LEE MEMORIAL HOSPITALFL748$1.28B17.4%
SARASOTA MEMORIAL HOSPITALFL787$1.10B8.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $50.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$14.5M+210bp18mo
Cost to Collect4.5%2.5%$13.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$13.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.4M+122bp9mo
Clean Claim Rate88.0%96.0%$441K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$14.5M
Cost to Collect
$13.8M
Denial Rate Reduction
$13.6M
A/R Days Reduction
$8.4M
Clean Claim Rate
$441K
Total EBITDA Uplift$50.7M
Current EBITDA$91.5M
+ RCM Uplift+$50.7M
Pro Forma EBITDA$142.2M
Current Margin13.3%
Pro Forma Margin20.7%
WC Released (1x)$26.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$140.8M$1.11B7.89x51.1%
Base (11x exit)10.0x11.0x$140.8M$1.27B9.00x55.2%
Bull Case9.0x11.0x$126.7M$1.48B11.68x63.5%
Bull (12x exit)9.0x12.0x$126.7M$1.65B13.04x67.1%
Bear Case11.0x10.0x$154.8M$811.2M5.24x39.3%
Bear (11x exit)11.0x11.0x$154.8M$942.6M6.09x43.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 56 hospitals with 291-1164 beds
  • Same-state prioritization (n=57)
  • Comp margins: P25=-7.0% / P50=5.2% / P75=16.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.